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Bioactive peptides (BPs) isolated from legumes have functional properties as 
healthy foods. These functional effects depend on their stability and bioavailability 
in the gastrointestinal tract before reaching the target organs. Therefore, it is neces-
sary to disclose the factors that influence it and discuss the technical processing to 
develop its utilisation. This chapter discusses and summarises the bioactive activities 
of BPs from various legumes, factors and mechanisms related to the bio-assessability, 
stability, bio-availability and bioactivity of BPs. Furthermore, the development of 
BPs bioseparation was also discussed. The results show that the nature of BPs var-
ies greatly depending on the legume source and the production method. Factors 
that influenced the bio-availability of BPs include molecular weight, charge, amino 
acid sequence, the presence of specific residues and hydrophobic amino acids, and 
resistance to the action of peptidase while in the digestive tract. However, some BPs 
showed increased bio-accessibility and bio-availability after being hydrolyzed by 
digestive enzymes. Processing technologies such as encapsulation allowing BPs to 
enter the body and undergo release and degradation by enzymes digestion. Further 
studies are required to understand the increase in the bioavailability of BPs, the safety 
of the food components produced, and their use in producing functional foods.
Keywords: Legumes, bioactive peptides, fermentation, germination, health benefits, 
bioavailability
1. Introduction
Legumes are a cheap and healthy source of nutrition because of their high 
protein content and complete constituent components, such as fats, essential amino 
acids, complex carbohydrates, vitamins, and minerals or dietary fibre. This high 
protein content plays an essential role in producing functional compounds such as 
bioactive peptides (BPs) that benefit the health and treatment of chronic diseases. 
For example, BP from legumes is used as an antioxidant compound to prevent 
degenerative diseases such as atherosclerosis, coronary heart disease, diabetes 
mellitus, and cancer [1, 2]. The number of deaths due to NCDs (non-communicable 
diseases), especially cardiovascular disease, cancer, chronic respiratory diseases, 
and diabetes, increases globally, both in low-income and rich countries. As a result, 
NCDs are still the cause of most global deaths each year [3]. One way to reduce the 
risk of NCD is controlling hypertension, regulating diet and obesity.
Protease enzymes have an essential role in producing BP as a result of protein 
hydrolysis. Food processing, microbial fermentation, germination, or other process 
involving protease enzymes are examples of proteolytic processes. The involvement 
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of protease enzymes in producing BP is significant because BP is mainly composed 
of 2–20 amino acids [4]. Some countries have healthy food products from legumes. 
Examples of fermented foods such as natto [5], douchi [6], tempe [7], and others, 
have antihypertensive activity. Fermented foods represent, on average, one-third 
of total food consumption [8]. Fermented food has a delicious taste, easy to digest, 
nutritious and has beneficial properties. Such as antidiabetic, hypocholesterolemic, 
and anti-inflammatory activities [8, 9].
Many researchers have proven (both in vitro and in vivo using experimental 
animals) that BP from legumes has functional properties as a healthy food. However, 
this functional effect depends on the stability of BP to withstand the action of diges-
tive enzymes while in the digestive tract on its way to reach the target organs [10]. In 
this target organ, BP will act to provide health effects for the body. One of the deter-
mining factors to be bioavailable is the number of amino acids, hydrophobic amino 
acid content, and resistance to digestive enzyme activity [11]. This chapter aims 
to describe the quality of various legumes, the BP of legumes and their effects on 
health. Also, an explanation of the factors that affect the stability, absorption, bio-
availability and bio-activity of BP and food technology to develop functional food.
2. Legume, as a source of bioactive peptides
One of the excellent sources of essential amino acids and protein is legumes. 
As a source of bioactive peptides (BPs), an ingredient must have a high enough 
protein content. In addition, legumes also contain many components needed for 
body health, such as antioxidant compounds, resistant starch, dietary fibre and 
others [12]. However, it is a fact that the nutritional content and phytochemical 
composition among legumes vary widely, as shown in Table 1. The differences in 
their genetics, varieties, geographical location and climatic conditions may cause 
the nutritional content variation [18].
In general, the protein content of legumes ranged from 17.0 to 39.8% (w/w). 
Soybean is the legumes that have the highest protein content. Soybean is also the 
most studied legume regarding its function on health. According to FAO [22] world 
soybean production in 2019 was 333,671,692 tonnes (the highest among the types of 
legumes produced), of which Brazil produced 34.25% as the world’s No. 1 producer 
country. Apart from soybean, some legumes also have a high protein content as a 
source of BPs, such as jack beans, velvet beans, lima beans, mung beans, and kidney 
beans (Table 1).
In addition to the protein content, it is also necessary to pay attention to the 
amino acid composition in choosing ingredients. Peptides with hydrophobic 
amino acids (Tyr, Phe, Trp, Ala, Ile, Val, and Met), positively charged amino acids 
(Arg and Lys), or contain Pro at the C end will have higher biological activity. 
For example, inhibition of ACE enzymes [23], Diabetes mellitus type 2 (T2DM) 
inhibitory activity [24], or other biological functions. Angiotensin-Converting 
Enzyme Inhibitor (ACEI), is a BP that affects lowering blood pressure. Meanwhile, 
DPP-IV inhibitors are compounds that can inhibit dipeptidyl peptidase-IV, an 
enzyme associated with T2DM disease [25]. So the presence of hydrophobic amino 
acids in short-chain peptides (between 2 and 20 amino acids in length) [4] is related 
to biological activities beneficial to health. Soybean, jack bean, velvet bean and 
mung bean are legumes that have high hydrophobic amino acid content (Table 1). 
Enzymatic breakdown through food processing produces short-chain peptides. For 
example, fermentation (to produce tempeh, soy sauce, natto, miso, douche, or other 
legume fermented products), germination (mung bean sprouts, soybean sprouts, or 
other sprouts), or other processes can break the polypeptide chain.
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Apart from these benefits, legumes contain substances that are considered 
anti-nutritional compounds [26]. Despite having a high protein content, some toxic 
anti-nutritional substances limit the use of legumes. Food processing, such as soak-
ing (hydration), cooking, autoclaving, germination, and combination, could reduce 
or eliminate anti-nutritional compounds [27, 28]; these processes can increase the 
digestibility value of protein ingredients. Table 2 shows some of the anti-nutritional 
compounds present in some legumes. Kalpanadevi and Mohan [26] said that the 
soaking process and continued germination was less effective in removing anti-
nutrients. However, the process would be effective if the germination process was 
extended (96 hours) or continued with the heating process (or autoclaving pro-
cess). With this combination process, the effect of anti-nutritional compounds can 
be eliminated, such as phenolics, tannins, hydrogen cyanide, phytic acid, trypsin 
inhibitors, oligosaccharides and Phyto-hemagglutination activity.
Other researchers stated that the fermentation process is also very effective for 
reducing/removing anti-nutritional compounds because the fermentation process 
is a combination of several processes, including soaking, heating, and proteolytic 
hydrolysis by starter microbes [31]. For example, the process of fermenting koro 
bean tempe (Canavalia ensiformis) for 48 hours can eliminate 100% of concana-
valin-A (Con-A) and reduce almost 99% of its HCN content [31]. Moreover, the 
fermentation process causes the percentage of peptides with MW <1 kDa to increase 
to the highest [33]. Short-chain peptides (between 2 and 20 amino acids) are associ-
ated with biological activities beneficial to health [4]. As shown by peptides from 
Phaseolus lunatus and Mucuna pruriens, peptides with MW < 1 kDa have higher ACE 
inhibitory activity [7, 34].
No Legumes sources Protein Amino acid hydrophobic
(db, % w/w) Reference (% w/w 
protein)
Reference
1 Soybean, Glycine max 35.35–39.80 [13] 37.70 [14]
2 Jack bean, white, Canavalia 
ensiformis L. DC
22.80–35.30 [14] 8.60–43.50 [14]
3 Sword bean, red, Canavalia 
gladiata jacq. DC
32.4–35.0 [15] 26.62–29.47 [15]
4 Cowpea, Vigna unguiculata 
L. Walp
20.90–24.70 [16] 8.46 [16]
5 Bambara groundnut, Vigna 
subterranea L. Verde
17.00–17.30 [16] 6.45 [16]
6 Velvet bean, White, Mucuna 
pruriens var. utilis
28.82 ± 0.14 [17] 34.14 [17]
7 Velvet bean, Black, Mucuna 
pruriens var. utilis
26.26 ± 0.07 [17] 32.79 [17]
8 Kidney beans, Phaseolus 
vulgaris L.
21.80–29.20 [18] 7.96 [16]
9 Lima beans, brown, Phaseolus 
luna tus
28.06 [7] 4.68 [7]
10 Mung bean, Phaseolus radiata 26.80 [19] 39.75 [20]
11 Chick pea, Cicer Arieti num 19.68–22.75 [16] 35.3 [21]
The level of hydrophobic amino acids is the sum of the data available in the reference sources used.
Table 1. 























1 Cowpea, Vigna 
unguiculata L. Walp.
1.21 0.38 2.46 0.4 26.48 2.2 NA NA [26]
2 Velvet bean, Black, 
Mucuna pruriens var. utilis
2.84 0.26 3.64 0.45 43.1 3.1 NA NA [17]
3 Velvet bean, White, 
Mucuna pruriens var. utilis
3.13 0.34 3.24 0.42 43.5 2.1 NA 4.49–6.08 [17, 29]
4 Sword Bean, red, 
Canavalia gladiate jacq 
DC.
1.21–1.41 0.16–0.20 2.32–2.64 NA 30.43–34.34 NA NA NA [16]
5 Kidney bean, Phaseolus 
vulgaris L.
NA 0.54–2.88 NA 1.68–2.41 3.65 NA NA 12.51 [19, 30]




NA NA NA 13.5–40.5 0.18–0.45 NA [17]
7 Jack Bean, white, 
Canavalia ensiformis L. 
DC.
3, 83 0.083 1.7 0.90 NA 59.95 NA 8.17 [28, 31]
8 Soybean, Glycine max 1.40–3.62 1.11–1.88 NA 0.51–2.45 23.67 NA NA 8.30–10.11 [27, 32]
NA, data not available in the references used.
Data is prepared and recalculated so that it has the same units.
Table 2. 
Anti-nutritional compounds in legumes.
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3. Bioactive peptides
Bioactive peptides (BPs) are tiny fragments of dietary protein, consisting of 2–20 
amino acids, have a molecular weight of less than three kDa, and promote health 
benefits. After entering the body, BPs can be absorbed in the intestine, carry out 
various metabolic pathways, and perform various physiological functions [4, 35, 36]. 
Several researchers have reported that legumes have various biological activities good 
for body health (Table 3).
The hydrolysis of legumes protein can produce these BPs. The enzymatic 
hydrolysis process occurs in the food processing process, for example, in the fruit 
ripening process, the fermentation process (producing soy sauce, tempe, natto, 
and other fermented products), or the germination process (producing soybean 
sprouts, green bean sprouts, and sprouts products others). In addition, the pro-
tein breakdown process can also be carried out by in vitro enzymatic hydrolysis, 
for example, using the alcalase in legume protein. Some examples of enzymatic 
hydrolysis are soybean hydrolysis (Glycine max) or mung bean hydrolysis (Vigna 
radiata), which produces BP hydrolysate as an ACE inhibitor [40, 45]. The in vitro 
enzymatic hydrolysis process will produce peptides with enormous structural 
diversity. Bioinformatics techniques using in silico studies can help select suitable 
peptide sources. Simulations of biological processes, such as enzyme hydrolysis, 
can use these in silico studies and further characterise processes and products using 
software/computers [61].
BPs can perform their activities and roles based on their structural properties, 
composition and amino acid sequence [62]. Biologically, the active peptides have 
similar structural properties, including the length of the amino acids, containing 
hydrophobic amino acids, and resistance to proteolysis [11]. For example, BPs with 
antioxidant activity have a length of 5–16 amino acids [63]. The structure of ACE 
inhibiting BPs contains arginine or lysine residues at the C-terminal will affect their 
activity [11]. Therefore, selecting the protease enzyme to form BPs is essential to 
produce biologically active peptides. For example, the Carlsberg enzyme subtilysin 
will hydrolyse peptide bonds with broad specificity to produce peptides with C 
terminal in the form of hydrophobic amino acids such as Phe, Tyr, Trp, Leu, Ile, Val 
and Met [64]. In addition, because of their relatively small size and high specificity, 
BPs can inhibit protein–protein interactions [65]. Some examples of the functional 
properties possessed by BPs are anti-hypertensive [66], antioxidants [67], hypo-
cholesterolemia [68], antimicrobials [69], anti-inflammatory [70, 71], anti-cancer 
[59], and other functional properties. One type of BPs can have more than one 
functional property [9, 65]. To date, researchers are still developing comprehensive 
studies and reviews to confirm the therapeutic effect of BPs. This chapter will 
discuss the BPs of legumes and their functions.
3.1 Antidiabetic
Increased blood sugar levels are signs of diabetes caused by decreased insulin 
secretion, impaired insulin function, or both. In patients with T2DM, the body 
does not respond adequately to insulin action and the blood glucose level increases, 
a condition known as hyperglycemia [72]. Changing diet is one way of treating 
diabetes, besides losing weight, exercising, or taking drugs to increase glucose 
homeostasis [25]. Side effects from synthetic antidiabetic drugs are gastrointestinal 
disorders [73]. Other side effects are hypoglycemia and weight gain [74].
Meanwhile, some patients are intolerant of the drug [75]. Therefore, research 
to find BPs from food as a safe antidiabetic has recently increased to overcome 
these side effects [76]. Measuring the inhibitory activity of DPP-IV is one way to 
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determine whether BPs have an antidiabetic activity or not. The role of the DPP-IV 
enzyme is to inactivate incretins, especially GLP-1 and GIP. GLP-1 is a glucagon-like 
peptide, while GIP is a glucose-dependent autotrophic insulin peptide. Incretin is 
a hormone that vitalising insulin secretion. So the mechanism commonly used to 
control T2DM is to measure how much DPP-IV inhibition is [77].
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The amino acid sequence of several bioactive peptides from legumes.
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Several low molecular weight BPs can induce insulin stimulation in blood 
intake, for example, the peptides present in fermented soybeans [78] or fermented 
kidney beans [9]. Some BPs that are isolated from black bean (Phaseolus vulgaris L) 
protein hydrolyzate effectively inhibits glucose transporter 2 (GLUT2) and glucose 
transporter, which depends on sodium 1 (SGLT1), which functions to lower blood 
glucose levels [39]. The BPs found in legumes (such as kidney beans, Phaseolus vul-
garis L with ten amino acids) have antidiabetic properties [9] (Table 3). The table 
states that the process can produce antidiabetic peptides, including fermentation, 
germination, or enzymatic hydrolysis.
3.2 Anti-hypertensives
Controlling hypertension is essential to reduce the risk of cardiovascular com-
plications such as coronary heart disease (which causes heart disease) and stroke, 
congestive heart failure, irregular heart rhythm, and renal failure [3, 79]. A healthy 
diet is a way to control hypertension. Eating foods high in BPs is very healthy. 
Several studies have shown that food ingredients derived from legumes have an 
anti-hypertensive function. The preparation of BPs uses three ways: fermentation of 
materials into fermented products, germination, and enzymatic hydrolysis. Table 3 
shows some of the research results.
The anti-hypertensive activity was measured by measuring the inhibitory activ-
ity of the ACE (Angiotensin I-converting Enzyme). The ACE will cut angiotensin I 
to produce angiotensin II (vasoactive peptide). This angiotensin II compound will 
bind to receptors on the walls of blood vessels causing contraction of blood vessels 
so that blood pressure rises [80]. The presence of BPs will bind to the ACE enzyme, 
thus inhibiting the action of ACE, and as a result, blood pressure can drop. Some 
legumes that are recognised to contain BPs that lower blood pressure include garden 
beans (Pisum sativum) [48], green beans [20, 40], soy (Glycine max) glycinin [41], 
kidney bean [9], and pigeon pea [49]. Fermented products also have anti-hyper-
tensive activity, such as douchi, a traditional Chinese food fermented soybean [8]. 
Other fermented products are Korean soybean paste fermented with mixed cultures 
of bacteria [81, 82], and many other products from legumes.
Research on anti-hypertensive BPs from food is still being studied [65]. Anti-
hypertensive BPs (isolated from food) have a higher tissue binding affinity than 
synthetic drugs, resulting in slower tissue loss [83]. For vigorous anti-hypertensive 
activity, the position of specific amino acid residues is critical. For example, valine 
and isoleucine are essential for ACE inhibition [84]. Increased ACE inhibitory 
activity occurs when the C-terminal is Proline [84]. Therefore, the strategy to pro-
duce peptides with high anti-hypertensive activity is to hydrolyse protein to produce 
proline containing peptides.
3.3 Hypo-cholesterolemic
Many researchers have studied and reviewed the ability of BPs as cholesterol-
lowering agents [65]. The human body needs healthy cholesterol levels to produce 
vitamin D and steroid hormones, and bile acids. However, arteriosclerosis can occur 
when cholesterol in the blood forms plaque in the arteries. As a result, it can reduce 
oxygen supply to the heart, which leads to cardiovascular disease. While chemicals 
that lower blood cholesterol can cause liver damage or failure, myopathy [85] and 
diabetes [86, 87], or some people are sensitive to statins (cholesterol-lowering 
drugs) [88]. Therefore, the research for BPs that can lower cholesterol has increased 
over the years [65]. Table 3 shows BPs in legumes (such as red beans and soybeans 
with 4–16 amino acids) with hypocholesterolemic activity.
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Cholesterol reduction by peptides can occur due to inhibition of cholesterol micelle 
formation, inhibition of lipase activity and strong bile acid-binding [89]. Peptides 
from fermented soy milk show the ability to bind bile acids [90]. The solubility of cho-
lesterol in lipid micelles will be reduced due to BPs [91], resulting in inhibition of cho-
lesterol absorption in Caco-2 cells with one layer. For example, peptides from cowpeas 
can inhibit HMGCoA reductase and reduce the dissolution of cholesterol micelles in 
vitro [92]. A 36% reduction in plasma cholesterol levels could occur in the livers of rats 
consuming the a’-subunit. The tight binding of BPs with taurocholate, deoxytauro-
cholate, and glycodeoxycholate can also lead to decreased cholesterol absorption in the 
intestine [93]. Soybean peptides (LPYP, IAVPGEVA and IAVPTGVA) can activate the 
LDLR-SREBP 2 pathway to increase LDL uptake effectively. For moderate hypercho-
lesterolemia, 30 g/ml lupine protein consumption effectively reduced the Proprotein 
Convertase Subtilisin/Kexin type 9 enzyme (PCSK9). Inhibiting HMGCoA reductase 
activity on HepG2 cells may explain the hypocholesterolemic effect of lupine protein 
hydrolysate [94]. In addition, peptides cause the regulation of lipoprotein b-VLDL 
cholesterol receptors to increase in rat liver [95].
3.4 Antioxidants
The antioxidant properties of peptides have more to do with their composition, 
structure, and hydrophobicity [62]. The amino acid sequence of these peptides can 
determine different biological activities. Amino acids Tyr, Trp, Met, Lys, Cys, and 
His are examples of amino acids that cause antioxidant activity [96]. BPs from some 
legumes have antioxidant properties, for example, soy peptides with 4–16 amino 
acids [42, 43] (Table 3). This table also shows that BP of Leu-Leu-Pro-His-His from 
soybean β-conglycinin hydrolysate has antioxidant properties. The amino acid 
leucine or proline at the N-end can increase its antioxidative activity [35]. Amino 
acids with aromatic residues can donate protons to electron-deficient radicals. 
This property enhances the radical scavenging character of amino acid residues. 
Amino acids in the C-terminal region can increase the antioxidant activity higher 
than in the N-terminal region. This increase in antioxidative activity relates to the 
nature of the electronic, hydrophobic, steric, and hydrogen bonding amino acids 
in the area [39]. Soy milk has significant antimutagenic and antioxidant activity. 
So fermented soy milk probably can prevent mutagenic and oxidative damage [97]. 
Consumption of douchi (fermented soy food) extract will increase the activity of 
SOD (Superoxide dismutase) in the liver and kidneys of mice. This consumption 
also reduces the serum TBARS (Thio Barbituric Acid Reactive Substance), which 
will increase catalase activity (CAT). These results may indicate the involvement of 
BPs and free amino acid components from douchi extract as antioxidants [98].
3.5 Antimicrobial
The ability of BPs as antimicrobial peptides (AMP) has also been widely 
researched and studied [65]. For example, Pina-Pérez and Ferrús-Pérez [55] studied 
AMP from several legumes against bacterial pathogens that cause foodborne 
diseases. AMP is generally active against a broad spectrum of microorganisms, 
including bacteria (Gram+ and Gram-), fungi, and viruses [99]. Some AMPs also 
show additional activity, such as antioxidant activity [100], immunomodulation 
[101] and wound healing activity [102]. Therefore, this AMP may be a better choice 
of antibiotics for pathogenic bacteria resistant to conventional antibiotics.
AMP has various characteristics, including amino acid length (between 12 and 
50), amino acid composition, charge and position of disulfide bonds [103]. AMP 
isolated from soybeans showed that long-chain peptides had higher AMP activity 
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than short peptides [55]. AMP interacts with microbes due to positive charges or 
hydrophilic and hydrophobic (amphipathic) terminal amino acids, recognised as 
a prominent structural motif. The charge, hydrophobicity and length of cationic 
AMP are directly related to their potential as antimicrobials [103]. AMP will cause 
changes in permeability and osmotic disturbances in bacterial cell membranes 
[104]. AMP can directly kill bacteria by creating pores through the bacterial cell 
membrane [101] or interacting with macromolecules in microbial cells [105]. The 
structure and sequence of peptide amino acids are the main factors for whether 
or not it is effective as an antimicrobial [104]. Some AMPs are rich in positively 
charged amino acids (arginine and lysine). Such AMP can enter microbial cells by 
inducing energy-dependent endocytic pathways such as micropinocytosis [106]. 
Table 3 shows some of the AMP amino acid sequences from soybeans.
3.6 Anti-inflammatory
Inflammation is a natural immune system reaction to fight disease. 
Inflammation is generally associated with cancer because it involves the interac-
tion of various immune cells that can lead to signals of proliferation, growth and 
invasion of tumour cells [107, 108]. There are two pathways of inflammatory-cancer 
interaction, namely the extrinsic pathway (inflammation facilitates cancer devel-
opment) and the intrinsic pathway (genetic changes causing cancer to stimulate 
the inflammatory process to support tumour development) [109]. Bastiaannet 
and co-workers [110] and Crawford [111] reported that anti-inflammatory 
therapy could reduce or prevent cancer risk. This report shows the interaction 
between inflammatory-cancer. So far, lunasin, VPY and -glutamyl peptides have 
anti-inflammatory activity [70]. Lunasin exerts an anti-inflammatory effect by 
inhibiting the Akt-mediated NF-kB pathway [57]. BPs from legumes, particularly 
soybeans, can regulate several inflammatory markers, which include prostaglandin 
E2 (PGE2), nitric oxide (NO), induced nitric oxide synthase (iNOS), cyclooxygen-
ase 2 (COX2), cytokines, and chemokines [70]. BPs from Phaseolus vulgaris L (the 
result of hydrolysis of alcalase and digestive enzymes pepsin and pancreatin) also 
showed similar results, inhibiting important markers and mediators of the inflam-
matory process [71]. Therefore BPs from Phaseolus vulgaris L can assist in managing 
diseases associated with chronic inflammatory processes such as T2DM and cancer. 
Several peptides from Phaseolus vulgaris L with anti-inflammatory activity are low 
molecular weight (MW) and contain 3–11 amino acids (Table 3). A lunasin-like 
peptide with low MW (5 kDa) inhibited the most potent pro-inflammatory markers 
than peptides with MW 8 and 14 KDa [112]. Biopsy of the small intestine mucosa 
showed repair in intestinal inflammation after supplementation of tempe in the diet 
[8]. Tempe contains many easily digestible compounds such as peptides and free 
amino acids that are affecting intestinal growth.
3.7 Anti-cancer
Many researchers are experimenting with cancer therapy using BPs from various 
legumes. The results are more promising, cheaper, and safer than cancer treatment 
using surgery, chemotherapy, or radiotherapy, which have adverse side effects due 
to the emergence of drug resistance and radio-resistance [113]. Extensive explora-
tion has shown that a high intake of legumes can significantly reduce the risk of 
colorectal adenoma [114, 115] BPs with anti-cancer activity have a relatively low 
molecular weight (Table 3), as isolated from black soybean by-products have the 
sequence Leu/Ile-Val-Pro-Lys [116]. In comparison, lunasin from soybeans contains 
43 amino acids [58]. The hallmark of lunasin is the Arg-Gly-Asp sequence which 
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functions for adhesion to the extracellular matrix, and the 8 Asp sequence to bind 
chromatin [117]. Kim and co-workers [118] said that hydrophobic BPs isolated from 
soybeans could act as anti-cancer. Some legumes also have higher hydrophobic 
amino acids that are similar in levels to soybeans, such as mung bean, chickpea, and 
velvet bean (Table 1), thus potentially producing anti-cancer peptides.
The mechanism of inhibition of tumour growth by BPs varies depending on the 
variety of legume sources, namely by induction of extrinsic apoptosis [119], induc-
tion of chromatin condensation [59] or inhibition of inflammatory processes [120]. 
BP isolated from chickpea (Cicer arietinum L.) inhibits the proliferation of breast 
cancer cells effectively [60]; this BP has the sequence ARQSHFANAQP. Meanwhile, 
BP from Phaseolus vulgaris (cultivar extra-long autumn purple) can also inhibit the 
proliferation of human tumour cells by inducing apoptotic bodies and nitric oxide 
[59]. Apoptosis (programmed cell death) is a complex process coordinated by spe-
cific target proteins and, in many cases, possibly responsible for the potential anti-
cancer effects [121]. Lunasin can reduce the incidence of skin tumours by 70% [58]. 
Also, it inhibits gastrointestinal cancer cells [122] and cardiovascular and immuno-
logical disorders [123]. The researcher reported that consumption of legumes could 
reduce the risk of 10 kinds of chronic diseases, including breast cancer, lung cancer 
and colon cancer [124]. Consumption of legumes in higher amounts will lead to a 
lower risk of death from cancer [125].
4. Bioacessability, stability, and bioavailability of bioactive peptides
Bioaccessibility, stability, and bioavailability are the main concerns in utilising 
bioactive peptides (BPs) from food ingredients to remain active in maintaining 
a healthy body. Bioaccessibility is the first step in the digestive system so that 
nutrients/BPs out of the food tissue and transported across the intestinal epithelial 
barrier into the blood circulation system. BP transport processes may involve pas-
sive transport (paracellular or passive diffusion) or active routes [126]. During the 
nutrient transport process, the stability of the material must be kept high, so the 
bioavailability of nutrients is maintained to be utilised by target cells or tissues. In 
the digestive tract, nutrients are released from the food matrix and converted into 
chemical forms that can bind to and enter intestinal cells or pass between them. 
Dietary factors can also affect the bioavailability of the BPs contained. Interactions 
between peptides and components of the food matrix can modulate their digestibil-
ity and alter the absorption route of the peptide [10]. The release of nutrients in the 
small intestine starts from chewing, which involves digestive enzymes in the mouth 
and then in the stomach mixed with acids and enzymes in gastric juices. This whole 
process is a process for making nutrients biologically accessible [127].
Although the number of active components in the food consumed is abundant, 
it cannot necessarily prevent disease because it depends on the amount available to 
function in target organs or tissues [128]. Bioavailability is the number of bioactive 
compounds that organisms can use effectively [129]. For example, when food contact 
with the mouth or gastrointestinal tract, various interactions can affect the bioavail-
ability of food nutrients (e.g., the presence of fat can increase the bioavailability 
of quercetin in food) [130]. In studying the role of bioactive compounds in human 
health, several factors can inhibit the bioavailability of the active components for use 
in target organs or tissues [131]. For example, fruit antioxidants mixed with macro-
molecules form a food matrix such as carbohydrates, fats, and proteins [132].
From a nutritional point of view, bioavailability refers to several nutrient 
fractions or bioactive compounds that are ingested and can reach the systemic 
circulation and can finally be utilised [133]. Besides that, bioavailability is the 
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fraction of a nutrient stored or available for a particular physiological function 
[134]. Another definition, bioavailability, is the amount of active metabolite from 
the oral dose fraction reaching systemic circulation [135]. The bioavailability of oral 
BPs is limited because their release from the plant matrix is affected by: solubility 
in GI fluids, permeability in intestinal epithelial cells, enzymatic and chemical 
reactions in the GI tract [136]. Four essential steps are required to absorb bioactive 
compounds effectively: (a) release from the food matrix; (b) incorporation into bile 
salt micelles; (c) absorption by epithelial cells; and finally; (d) incorporation into 
the cyclomicron secretion into the lymphatic system.
The biological effects of a BP depend on its capacity to survive until it reaches 
the target organ. Thus, the main requirement of a BP is its stability or resistance 
to gastrointestinal enzyme hydrolysis, brush border and serum peptidase. 
Experimental evidence shows that the length of the peptide chain determines 
the ability of BPs to pass through the intestinal epithelium in humans by differ-
ent mechanisms. For small peptides, it is possible to transport through active 
basolateral, while for large peptides through a transport mechanism mediated by 
exocytotic-vesicles [137].
However, many peptides are biologically active but are unlikely to be absorbed in 
the gastrointestinal tract via local effects or receptors that release hormones and cell 
signalling in the gut. Such BPs affect gastric emptying, gastrointestinal transport, 
nutrient absorption (amino acids, glucose, lipids) and composition of the colon 
microflora. They may also regulate food intake [138].
In addition to the presence of specific residues, charge, and molecular weight, 
hydrogen bonding potential and amino acid hydrophobic tend to affect the bioavail-
ability resistance of BPs to proteases and enzyme hydrolysing peptides [11, 139, 
140]. Lunasin, a BP isolated from soybeans and cereal (wheat, barley and rice), has 
43 amino acids (MW 5.4 kDa), displays a helical structure and contains nine aspar-
tic acid residues in the C-terminal region. Lunasin is highly bioavailable, heat-stable 
(100°C, 10 min), and anti-cancer against carcinogenic chemicals. In vivo digestibil-
ity of lunasin-fortified soy protein was studied in mice fed for four weeks [141].
During transit in the central digestive tract, the structural properties of the 
peptide will influence the stability of BPs, including molecular weight, charge, 
amino acid sequence, and hydrophobicity [126]. Tests using Sprague Dawley rats 
showed that the highest absorption of ACE inhibitor BPs was in the jejunum [7]. 
The results showed that BPs with 2–6 amino acids were easy to absorb than proteins 
and free amino acids [142]. Small (di- and tripeptide) and large (10–51 amino acids) 
peptides can pass through the intestinal barrier and exhibit their biological func-
tion at the target tissue level. However, as the molecular weight of BPs increases, 
their chances of passing through the intestinal barrier decrease further [143]. The 
presence of proline and proline hydroxyl will result in resistance of BPs to digestive 
enzymes, especially a tripeptide with Pro-Pro at the C-terminal [144]. In another 
study, the number of peptides in human plasma increased depending on the dose of 
the BP administered. Thus, it concluded that the saturation of BP transporters could 
affect the number of peptides that can enter the peripheral blood [145].
Encryption of BPs in their natural protein structure may protect these BPs from 
gastric digestion. Another way to protect BPs is to modify structural proteins such 
as phosphorylation of serine, threonine, or tyrosine can prevent hydrolysis by 
digestive proteases. As a result, protein or peptides have a greater chance of being 
absorbed in target organs or tissues [146]. Stability also depends on the degree of 
hydrophobicity/hydrophilicity. The more hydrophobic the structure, the more 
difficult it is to attack by proteases [147].
Therefore, it explained that the difference in bioavailability of BPs between in 
vitro and in vivo tests (after oral consumption), which may be smaller or larger, 
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occurs due to an increase or decrease in BPs after being catalysed by gastrointestinal 
proteases. A simulation test of the gastrointestinal digestion process of several 
tempe legumes (Phaseolus lunatus L, Canavalia ensiformis L, Mucuna pruriens) 
showed that the proteolysis process by the digestive enzyme pepsin-pancreatin 
increased ACE inhibitory activity [7, 31, 34]. Another example is that BPs’ anti-
oxidant activity in vivo is more significant than in vitro [148]. The shape of the 
molecular structure also influences the stability of BPs. For example, a small BP 
(YPI) isolated from ovalbumin has additional stability when tested in GI digestive 
system simulation. BPs (YPI) and peptides containing P at the C end (RADHP and 
ADHP) are stable. If their structure is slightly modified by adding one or two amino 
acids to the C end (e.g. RADHPF, RADHPFL, FRADHPFL), they become unstable 
in simulated GI hydrolysis [149].
Finally, the use of BPs in nutraceutical and pharmacology for human health is 
still limited. For that, it is necessary to evaluate: (1) degradation of BPs by proteases 
in the digestive tract, which can affect bioaccessibility, stability, and bioavailability; 
(2) the existence of technology that allows modification of the structure of BPs 
such as (a) phosphorylation of amino acids in BPs to make them more resistant to 
hydrolysis by digestive enzymes; or (b) increase the amino acid hydrophobic at the 
N-terminal or C-terminal [150].
5. Technology for bioactive peptides
In general, protein-rich foods that undergo processing involving protease 
enzymes will produce peptides. However, not all peptides resulting from protein 
hydrolysis of foodstuffs will become bioactive peptides (BPs) beneficial to body 
health. The structural properties of BPs (composition, amino acid sequence, hydro-
phobic amino acid content, and resistance to digestive enzymes) will determine 
their beneficial functional properties [126], such as, example anti-diabetic, anti-
hypertensive, cholesterol-lowering, antioxidant, and other functional properties.
Food processing processes related to conventional BPs production include cooking, 
ripening, fermentation and germination. In principle, the processing involves protease 
enzymes, e.g., chymotrypsin, trypsin, papain, thermolysin, and others) [151], either 
in the form of free or immobilised enzymes. For food processing by fermentation, 
protease enzymes derived from microbes are used in the process, while for germina-
tion, the enzymes are from growing seeds. Production of BPs increased by regulat-
ing the types of enzymes, microbes used, and germination time. Combining these 
processes (enzymatic process followed by fermentation, or vice versa) will increase 
the production of BPs so that it is more optimal [152]. The conventional production of 
the BPs product was a low amount and purity, making it less effective for the indus-
trial scale [153]. So this conventional method for producing BPs does not necessarily 
involve a separation and purification process, but the production of functional foods 
containing healthy BPs in the form of fermented food products [153].
The process technology used to produce functional or nutraceutical food will 
affect the functional, nutritional and biological properties of the protein in the 
food. Therefore, several things to pay attention to, namely: (1) the effect of using a 
thermal (or non-thermal) process on the components of the food produced, includ-
ing its effect on its functional properties and preservation capabilities; (2) available 
extraction processes and formulations and their optimization; (3) innovative and 
sustainable applications that can be developed [127]. In addition, consideration of 
the choice of processing technology must also be based on the desired nutritional 
function and appearance and sensory properties (such as colour, texture, and taste 
in the mouth) to be attractive to consumers [154]. Thermal processes can encourage 
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non-enzymatic Maillard reactions between amino groups and reducing sugars 
[155]. This process will produce colour, sensory properties that affect consumer 
acceptance and reduce the activity of BPs [155, 156]. The use of thermal processes 
(e.g. boiling, cooking, blanching, frying, and sterilising) for softening cell walls 
and inactivate microorganisms and enzymes to make the shelf life longer [127]. The 
development of non-thermal processes has several weaknesses; for example, the 
use of nanofiltration membranes requires energy [157]. Freeze-drying, encapsula-
tion, and solvent extraction techniques are costly. To overcome this limitation, food 
technology experts must develop new alternative technologies (technology that can 
maintain bio-accessibility, stability, bio-availability and bio-activity of active com-
ponents). Including BPs, processed food ingredients and the form of pure isolates 
(capsules or nanocapsules).
The production of BPs has become more accessible, faster, and more effective 
with the development of science and technology. Production of BPs on an industrial 
scale usually uses an enzyme hydrolysis process. So the BPs production process uses 
computer equipment and database search algorithms to predict target peptides and 
their properties. By selecting the correct protease enzyme through the database, it 
is possible to select the protein-enzyme combination, in-silico hydrolysis, and the 
nature of the peptide to be produced [152, 153, 158]. This in-silico hydrolysis method 
is a functional and widely practised approach for producing legume BPs (Table 3).
The legume or various food peptides resulting from enzymatic hydrolysis was 
then fractionated and purified using a combination of various chromatographic 
techniques [158–160]. Isoelectric focusing and ultrafiltration are separate mac-
romolecular compounds (such as protein and pectin). Meanwhile, extraction 
techniques use solvents or supercritical solutions to isolate small molecule bioac-
tive compounds such as antioxidants [157, 161, 162]. This extraction technique, 
combined with thermal technology (e.g. pasteurisation or spray drying), has been 
applied to functional foods. This conventional food processing technology is well 
documented and well established, but its application for the isolation of BPs still 
needs development and improvement.
The weakness of current technology is that there is still a need for studies on 
product safety for health. For example, advanced technologies such as cold plasma, 
nanotechnology, ultrasound, and others, are thought to affect advanced lipid 
oxidation processes and cause cell tissue damage. For this reason, the effect of this 
advanced technology on the safety and health of the food components produced 
needs to be studied to obtain a complete understanding. In this case, it is necessary to 
adapt the product and technology to the desired functional properties of the active 
ingredient. For example, modification or interaction with other macronutrients (e.g. 
dietary fibre) can increase the bio-availability of bioactive compounds [163].
On the other hand, encapsulation technology using legume protein ingredients as 
a material is also a technique for providing chemical compounds found naturally in 
plants and other nutraceutical compounds (such as vitamins, minerals, BPs, or others). 
Thus this encapsulation allowing these compounds (including BPs) to enter the body 
and undergo release and degradation by enzymes digestion [164]. Other technologies 
used to protect the active ingredients or nutraceuticals (such as BPs and others) are 
encapsulation, edible films and coatings, and vacuum impregnation. One may be 
promising is nutrigenomics, where the active ingredients are given to individuals on a 
Taylor-made basis according to the genetic characteristics of each individual [165].
Although several researchers have evaluated and characterised BPs that BPs 
isolated from food have potential bioactive activity and therapeutic functions, 
and have high bio-availability (bio-accessibility) (due to the support of excellent 
and modern processing technology), however, all of them can only have a positive 
impact on human health when combined with healthy living habits [4].
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6. Conclusions
Legumes have various biological activities that are good for body health, such as 
antihypertensive, anti-diabetic, anti-cancer, antioxidant, and others, but legumes 
also contain anti-nutritional compounds. Food processing is an effective process to 
remove anti-nutritional compounds and, at the same time, can produce BP com-
pounds that are healthy for the body. Although the number of active components 
in food is abundant, it is not necessarily able to prevent disease because it is very 
dependent on the amount available to function in target organs or tissues. One of 
the contributing factors is the BPs enzyme in holding the action while in the diges-
tive tract. Some legumes showed that hydrolysis by these enzymes increased their 
bio-accessibility and bio-availability in the digestive tract of rats (in antihyperten-
sive testing). Due to the diverse nature of BP, it is necessary to develop technology 
that is following the desired functional properties of BP, for example, to protect it so 
that it is stable while passing through the digestive tract using microencapsulation, 
edible film and coating technology. Further research still needs to be developed 
related to the study of safety separation technology for the products produced. 
From the excellent stability and bioavailability of BPs from legumes, it is likely to be 
more promising to develop alternative healthy functional food products containing 
BPs and sensory properties that attract consumers.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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